{"denoms":[{"counts":[{"groupId":"BG000","value":"239"},{"groupId":"BG001","value":"241"},{"groupId":"BG002","value":"480"}],"units":"Participants"}],"groups":[{"description":"Participants received intravenous infusions of placebo at Weeks 0, 4, 12 and 20.","id":"BG000","title":"Placebo (Week 0-24)"},{"description":"Participants were randomized to receive intravenous infusions of golimumab 2 mg/kg at Weeks 0, 4 and every 8 weeks thereafter up to Week 52. At Week 24, participants received a placebo intravenous infusion to maintain the blind.","id":"BG001","title":"Golimumab 2 mg/kg"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"2"}],"title":"<=18 years"},{"measurements":[{"groupId":"BG000","value":"216"},{"groupId":"BG001","value":"228"},{"groupId":"BG002","value":"444"}],"title":"Between 18 and 65 years"},{"measurements":[{"groupId":"BG000","value":"21"},{"groupId":"BG001","value":"13"},{"groupId":"BG002","value":"34"}],"title":">=65 years"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Categorical","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"12.53","value":"46.7"},{"groupId":"BG001","spread":"11.25","value":"45.7"},{"groupId":"BG002","spread":"11.9","value":"46.2"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"118"},{"groupId":"BG001","value":"113"},{"groupId":"BG002","value":"231"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"121"},{"groupId":"BG001","value":"128"},{"groupId":"BG002","value":"249"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"14"},{"groupId":"BG001","value":"8"},{"groupId":"BG002","value":"22"}]}],"title":"Belarus"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}]}],"title":"Canada"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"4"}]}],"title":"Germany"},{"categories":[{"measurements":[{"groupId":"BG000","value":"13"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"22"}]}],"title":"Hungary"},{"categories":[{"measurements":[{"groupId":"BG000","value":"13"},{"groupId":"BG001","value":"17"},{"groupId":"BG002","value":"30"}]}],"title":"Lithuania"},{"categories":[{"measurements":[{"groupId":"BG000","value":"43"},{"groupId":"BG001","value":"34"},{"groupId":"BG002","value":"77"}]}],"title":"Poland"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"4"}]}],"title":"Romania"},{"categories":[{"measurements":[{"groupId":"BG000","value":"79"},{"groupId":"BG001","value":"74"},{"groupId":"BG002","value":"153"}]}],"title":"Russian Federation"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"3"}]}],"title":"Spain"},{"categories":[{"measurements":[{"groupId":"BG000","value":"61"},{"groupId":"BG001","value":"86"},{"groupId":"BG002","value":"147"}]}],"title":"Ukraine"},{"categories":[{"measurements":[{"groupId":"BG000","value":"8"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"17"}]}],"title":"United States"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Region of Enrollment","unitOfMeasure":"Participants"}]}